New York Proton Center Showcases Proton Therapy Innovations at PTCOG 64
The New York Proton Center (NYPC), a leader in proton therapy research, is presenting new data on the benefits of proton therapy for various cancers at the 64th Annual Conference of the Particle Therapy Cooperative Group (PTCOG 64) in France. The NYPC, the only proton therapy center in New York, is sharing insights on the use of proton therapy in treating spinal, uterine, cervical, thoracic, gastrointestinal, breast, CNS, and head and neck cancers. The center is also highlighting innovations such as ultra-high dose rate FLASH therapy. Dr. Charles B. Simone, II, the Chief Medical Officer of NYPC, is leading several sessions at the conference, emphasizing the center's commitment to advancing proton therapy as a standard cancer treatment. The NYPC's collaboration with Memorial Sloan Kettering, Montefiore, and Mount Sinai is crucial in bringing these advancements to patients.